Canopy Growth Reports Revenues of $110.4 Million, Net Loss of $128.3 Million For Q1 2021

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) this morning reported its first quarter financials for the period ended June 30, 2020. The company reported net revenues of $110.4 million, while posting a net loss of $128.3 million for the quarter, a marginal increase over revenues of $107 million in the fourth quarter of fiscal year 2020.

Thr bright side from this quarters financials, is that the company managed to post a positive gross margin, even if it only came in at 6%. In dollar terms, gross margin amounted to $6.5 million. In terms of revenue segments, on a year over year basis Canopy’s revenues from the recreational market fell by 11%, from $49.5 million to $44.2 million. Comparatively, global medical revenue grew by 54% to $34.1 million, from $22.2 million. All other revenue also grew on a quarter over quarter basis, from $18.8 million to $32.1 million. Comparatively, sales were up 22% from $90.5 million year over year.

The operation itself however has yet to prove its sustainable, with Canopy recognizing $178.9 million in total operating expenses for the quarter, of which $135.4 million was classified as selling, general and administrative expenses. Asset impairments and restructuring costs came in at $12.8 million for the quarter.

Nord Precious Metals — sponsored Sponsored · Nord Precious Metals

The loss for the quarter however was reduced as a result of “other income” of $48.2 million along with an income tax recovery of $3.0 million, bringing the net loss for the quarter to $128.3 million, despite the massive operating expenses exhibited by the firm.

Looking to the balance sheet, the firm saw its cash and cash equivalents deplete to $975.9 million from $1,303.2 million in the previous quarter. However, this was largely offset by short-term investments climbing to $1,060.9 million from $673.3 million, with the overall boost in the firms cash position a result of the $245 million received by the company from Constellation Brands (NYSE: STZ) exercising certain warrants during the quarter. Accounts receivable declined to $72.6 million from that of $90.2 million, while inventory remained relatively flat at $389.8 million, down marginally from $391.1 million in the prior quarter. Total current assets is currently pegged at $2,613.9 million.

Accounts payable meanwhile fell from $123.4 million to that of $89.4 million, while other accrued expenses climbed to $83.0 million from $65.0 million. Other liabilities fell significantly, from $420.6 million to $319.7 million. Total current liabilities came in at $319.7 million.

Finally, the company also reported that its free cash flow for the quarter amounted to -$180.1 million, an improvement from -$379.1 million in the year ago period.

The company has yet to file full financials statements with Sedar as of the time of writing.

Canopy Growth Corp last traded at $16.63 on the NYSE.


Information for this briefing was found via Sedar and Canopy Growth. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Canopy Growth Very Quietly Released A Weed-Growing Game

A Twitter user recently discovered a “Zelda-type” 2D weed-growing game from following QR codes printed...

Monday, April 4, 2022, 04:37:00 PM

Canopy Growth Posts 9% Revenue Decline, Continued Net Losses In Q2 FY2025

Canopy Growth Corporation (TSX: WEED) released its Q2 FY2025 results today, revealing a mixed financial...

Friday, November 8, 2024, 07:48:52 AM

Canopy Growth Begins Production at New Large Scale Bottling Facility

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) announced today that they have acquired Health Canada...

Monday, November 25, 2019, 03:33:48 PM

Canopy Growth Sees BioSteel Assets Sold Off Under CCAA Process

Canopy Growth (TSX: WEED) might yet get some value for its failed BioSteel division following...

Friday, November 17, 2023, 08:18:45 AM

Canopy Growth Reports Cannabis Segment Impairments Of $1.7 Billion In Q1 2023

Canopy Growth (TSX: WEED) continues to see its role within the Canadian cannabis landscape diminish....

Friday, August 5, 2022, 08:18:19 AM